http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2489146-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_993cec06fc2a6aec3ac3d548408f5ba0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b0ff8da3ae3d9dbae53a6d25fc2a01b |
| publicationDate | 2013-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2489146-C1 |
| titleOfInvention | Method of treating "dry" form of age-related macular degeneration |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, in particular opthalmology, and may be used for treating the patients with a "dry" form of age-related macular degeneration. That is combined with using lutein-containing antioxidants and carotenoids for one year every 2-3 months. Fenofibrate (Tricor 145) is additionally used for a period of time long enough to normalise a lipid profile and to maintain the above values at the attained level. Vitrum vision forte and nutrof total are used as the above lutein-containing antioxidants and carotenoids. n EFFECT: invention provides arresting the progression of the "dry" form of age-related macular degeneration. n 2 cl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2776877-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2559090-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020227366-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2755890-C1 |
| priorityDate | 2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.